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Objective. The purpose of this study was to evaluate the frequency of focal fibrosis of the breast diag-
nosed by a sonographically guided core biopsy of nonpalpable lesions, to characterize imaging fea-
tures, and to evaluate their clinical relevance. Methods. In a retrospective review of 724 lesions that
underwent sonographically guided core biopsy of nonpalpable breast lesions, 62 cases had a diagno-
sis of focal fibrosis. Two radiologists analyzed the sonographic and mammographic findings according
to the Breast Imaging Reporting and Data System. The results were compared with histologic findings
at surgery or imaging findings during surveillance. Results. The incidence of focal fibrosis was 8.6%
(62/724). Sonographic films were available in 56 cases, so 56 cases were reviewed for their sono-
graphic findings. Among the mammograms reviewed, 64.7% (33/51) had negative findings. Among
the sonograms reviewed, the most common features were oval shape (32/56, 57.1%), parallel orien-
tation (36/56, 64.3%), microlobulated margin (24/56, 42.9%), abrupt interface (50/56, 89.3%), isoe-
choic pattern (42/56, 75.0%), and a lack of posterior acoustic features (45/56, 80.4%). The Breast
Imaging Reporting and Data System final assessment was category 3 in 27 (48.2%) and category 4 in
29 (51.8%). Most of the category 4 lesions were category 4A (26/29, 89.7%). Surgical excision (n =
7) and follow-up for at least 1 year (n = 49) showed no malignancy. Conclusions. Focal fibrosis was
found in 8.6% by a sonographically guided core biopsy of nonpalpable breast lesions. Most of the
lesions were categorized as probably benign (category 3) or having a low suggestion of malignancy
(category 4A). Focal fibrosis diagnosed at core biopsy can be managed with a 6-month follow-up pro-
tocol. Key words: breast abnormalities; breast biopsy; fibrous nodule; sonography.
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ocal fibrosis of the breast is a histopathologic enti-
ty characterized by proliferation of the stromal
connective tissue with obliteration of the mamma-
ry ducts and lobules.1 It has been described by a
variety of terms, including focal fibrosis, stromal fibrosis,
focal fibrous disease of the breast, fibrous mastopathy,
fibrous tumor of the breast, and chronic indurative mas-
titis.1,2 It has become a common diagnosis after a core
needle biopsy of the clinically occult, mammographical-
ly or sonographically detected breast lesions. The inci-
dence of focal fibrosis was reported to be 3.6% to 8.2% of
lesions that underwent an imaging-guided core biopsy.2–7
Focal fibrosis has been described as having variable
mammographic and sonographic features. Recent stud-
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ies reported that many of them were presented as
well-defined benign-looking masses on a sono-
graphic examination, but sonographic evalua-
tion using the Breast Imaging Reporting and
Data System (BI-RADS) has not been reported.
To our knowledge, imaging findings and clinical
relevance of nonpalpable focal fibrosis diag-
nosed by sonographically guided biopsy have
not been reported.
We conducted a retrospective review of records
to evaluate the frequency of focal fibrosis of the
breast diagnosed by a sonographically guided
core biopsy of nonpalpable lesions, to character-
ize the sonographic features of focal fibrosis
according to BI-RADS, and to evaluate its clinical
relevance.
Materials and Methods
We retrospectively reviewed the pathologic
reports of 724 cases of sonographically guided
core biopsies of nonpalpable breast lesions per-
formed from March 2001 to December 2002.
Focal fibrosis was the diagnosis in 70 cases.
Among these cases, the patients with a previous
surgical biopsy at the site were excluded
because a surgical scar usually shows only fibro-
sis on pathologic examination. One pathologist
reviewed the pathologic slides, and our study
included 62 lesions in 60 patients with the diag-
nosis of only focal fibrosis without evidence of
diabetic mastopathy, fibromatosis, or other
stromal lesions. The mean age of the patients
was 47 years (range, 21–73 years). None of the
patients had diabetes. Six patients had a history
of breast cancer (5 contralateral and 1 ipsilater-
al), and 4 had a family history of breast cancer.
All of the sonographic examinations were per-
formed by 3 radiologists specializing in sonogra-
phy of the breast using either an HDI 3000 or HDI
5000 system (Philips Medical Systems, Bothell,
WA) and electronically focused near-field probes
with a bandwidth of 5 to 10 or 5 to 12 MHz. The
examiner knew the results of clinical examina-
tion and mammography at the time of the sono-
graphic examination.
We reviewed the sonographic findings, includ-
ing size, shape, orientation, margin, lesion
boundary, echogenicity, and posterior acoustic
changes of the nodules according to BI-RADS.8
The size of the lesions was measured in the long
diameter on the sonogram. Other classifications
included the shape (oval, round, or irregular),
margin (circumscribed, indistinct, angular, or
microlobulated or spiculated), lesion’s boundary
(abrupt interface or echogenic halo), and
echogenicity of the nodule (anechoic, hypoe-
choic, isoechoic, or hyperechoic compared with
echogenicity of subcutaneous fat). The posterior
acoustic phenomenon associated with the nod-
ule was divided into 3 categories: no acoustic
change, posterior acoustic enhancement, and
posterior shadowing. Orientation of the nodule
was classified as parallel or not parallel.
Mammograms were available in 51 cases.
Mammography in 2 standard imaging planes
(mediolateral oblique and craniocaudal) was per-
formed with dedicated equipment (Senographe
DMR; GE Healthcare, Milwaukee, WI). The mam-
mographic findings were classified as having no
abnormality, mass, mass with calcification, asym-
metric density, calcification only, or architectural
distortion. In cases of a mass, the findings were
further divided by shape, border, and density.
Mass shape was described as round, oval, lobular,
or irregular. Mass margin was characterized as cir-
cumscribed, microlobulated, obscured, indistinct,
or spiculated; and lesion density was categorized
as high, equal, or low relative to that of the breast
parenchyma. The final assessment was made by
the 6-category system according to BI-RADS.8
The BI-RADS category is shown in Table 1, and it
was assigned as follows: BI-RADS category 1 for
normal; BI-RADS category 2 for lesions classified
as benign; BI-RADS category 3 for lesions classi-
fied as probably benign; BI-RADS category 4 for
lesions classified as suggestive; BI-RADS category
5 for lesions classified as highly suggestive of
malignancy; and BI-RADS 6 for known malignan-
cy. Category 4 was subdivided further as follows:
category 4A for those with a low suggestion of
malignancy, category 4B for intermediate con-
cern of malignancy, and category 4C for moderate
suggestion but not classic for malignancy. When
the breast sonographic examination was per-
formed with mammography, a single final assess-
ment was made, which reflected the combined
mammographic and sonographic findings.
The sonograms and mammograms were
independently and retrospectively reviewed by
2 experienced radiologists. Both films were
reviewed together for each patient. Any dis-
crepancy was resolved by consensus.
All biopsy procedures were performed by
dedicated breast-imaging radiologists using a
freehand technique with a 14-gauge Tru-Cut
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automated core biopsy needle and a spring-
loaded biopsy gun (Promac 2.2; Manan
Medical Products, Wheeling, IL) under sono-
graphic guidance. At least 5 samples were
obtained (mean, 6; range, 5–8).
Follow-up data were also analyzed, including
after surgical excision (n = 7) and after imaging
studies (n = 49). 
Results
Focal fibrosis was diagnosed in 62 cases (8.6%) of
724 sonographically guided core biopsies. The
mean size of the lesions was 9.4 mm with a range
of 4–22 mm.
Sonographic films were available in 56 cases
(summarized in Table 2). All lesions were repre-
sented as a mass on sonographic examination.
The shape of the nodule was oval in 32 cases
(57.1%; Figures 1 and 2), and in 24 cases (42.9%),
it was round or irregular (Figures 3 and 4). In 36
cases (64.3%), the nodules were parallel orient-
ed, whereas in the remaining 20 cases, the nod-
ules were not parallel. The margin was not
circumscribed in 36 cases (64.3%), including a
microlobulated margin in 24 cases (42.9%;
Figure 3), an indistinct margin in 9, and an angu-
lar or a spiculated margin in 3. The remaining 20
cases (35.7%) had a circumscribed margin. Fifty
cases (89.3%) had an abrupt interface of the
lesion boundary. Most of the lesions showed
either an isoechoic or a hypoechoic (54/56,
96.4%; Figures 1–4) echo pattern to the subcuta-
neous fat. Eighteen cases (14.3%) showed poste-
rior shadowing (Figure 4).
Mammographic findings are shown in Table 3.
Eighteen cases (35.3%) had positive findings on
the mammogram, but 33 cases (64.7%) had neg-
ative findings. These 33 lesions were detected
only in the sonographic examination of mam-
mographically dense breast (n = 29) and in a part
of the breast separate from the palpable mass
during the evaluation of palpable masses (n = 4).
Mammographic findings included a mass with
or without calcifications in 14 (27.4%), asymme-
try in 2 (3.9%), and architectural distortion in 2
(3.9%; Figure 5). In the cases of masses identified
on mammography (n = 14), the masses were
round in 8, oval in 2, and lobular in 1 (Figure 1).
The margin of the masses was circumscribed in
4, microlobulated in 2, obscured in 6, and indis-
tinct in 2. The density was isodense in 10 and
high in 4.
Twenty-seven (48.2%) lesions were classified as
category 3 (Figure 1), and 29 (51.8%) lesions were
classified as category 4 (Table 4). Most of the cat-
egory 4 lesions were category 4A (26/29, 89.7%;
Figures 2 and 3). Of 56 cases, 7 (12.5%) under-
went excisional biopsy. The reasons for excision-
al biopsy were imaging-pathologic discordance
(n = 3; Figures 4 and 5) and physician or patient
desire (n = 4). The surgical results were all benign.
This information is summarized in Table 5.
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Table 1. Final Assessment Category by BI-RADS
Final Assessment 
Category Definition
Category 1 Normal
Category 2 Benign
Category 3 Probably benign
Category 4 Suggestive
4A Low suggestion of malignancy
4B Intermediated concern of malignancy
4C Moderate suggestion but not classic for malignancy
Category 5 Highly suggestive of malignancy
Category 6 Known malignancy
Table 2. Sonographic Findings of Focal Fibrosis
Diagnosed by Sonographically Guided Core Biopsy
(n = 56)
Sonographic Findings Cases (%)
Shape
Oval 32 (57.1)
Round 16 (28.6)
Irregular 8 (14.3)
Orientation
Parallel 36 (64.3)
Nonparallel 20 (35.7)
Margin
Circumscribed 20 (35.7)
Not circumscribed
Indistinct 9 (16.1)
Angular 2 (3.6)
Microlobulated 24 (42.9)
Spiculated 1 (1.8)
Lesion boundary
Abrupt interface 50 (89.3)
Echogenic halo 6 (10.7)
Echo pattern
Hyperechoic 1 (1.8)
Isoechoic 42 (75.0)
Hypoechoic 12 (21.4)
Complex 1 (1.8)
Posterior features
None 45 (80.4)
Enhancement 3 (5.4)
Shadowing 8 (14.3)
The remaining 49 cases were followed by
sonography and mammography for an average
of 20 months (range, 12–38 months) of follow-
up, including 39 cases (79.6%) of at least 2 years.
The follow-up sonographic examinations were
done in 6-month intervals for 2 years, and
mammography was done yearly. Thirty-four
(69.4%) cases showed no interval change of size
on follow-up, and 15 cases (30.6%) showed a
decrease in size.
Discussion
Recently, several articles about focal fibrosis have
been published. This might be due to the com-
monly used imaging-guided biopsy,2–6 but focal
fibrosis diagnosed solely by sonographically
guided biopsy has not been reported yet.
Interestingly, 33 (64.7%) of 51 women who
underwent mammography had a negative result
in our study. The fibrosis was incidentally found
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Figure 1. Focal fibrosis in a 42-year-old woman. A mammogram (A) reveals an oval isodense nodule (arrow) with an indistinct margin. A transverse
sonogram (B) reveals an oval, circumscribed, isoechoic nodule with a parallel orientation. The diagnosis of the core biopsy was focal fibrosis. The lesion
did not change during 36-month imaging follow-up. 
A B
Figure 2. Focal fibrosis in a 41-year-old woman. A mammogram (not shown) revealed heterogeneously dense breasts without remarkable findings.
Transverse (A) and longitudinal (B) sonograms reveal an oval, hypoechoic nodule with a parallel orientation. The lesion has indistinct margins, especial-
ly on the lateral side. We suggested it was a category 4A lesion, and focal fibrosis was diagnosed by a sonographically guided core biopsy. The lesion
did not change during 32 months.
A B
during the sonographic examination of mam-
mographically dense breasts or during the exam-
ination of palpable masses. Several articles about
the sonographic examination of mammographi-
cally dense breasts have been published.9–15 In 1
study, 21 sonographically guided core needle
biopsies (1.4%) were performed in 1517 women
with breast tissue density designated as BI-RADS
density categories 2, 3, and 4.14 Among these, 14
had benign results, and the diagnosis of 3
(21.4%) of 14 was fibrosis. Their sonographic
findings, however, were not described. We can
project that the full-scale sonographic examina-
tion would show more nonspecific suggestive
nodules and increase focal fibrosis diagnosed by
a sonographically guided core biopsy.
The incidence of focal fibrosis was found to be
about 3.6% to 8.2% of lesions in patients who
underwent an imaging-guided core biopsy.2–6 In
our study, the incidence was relatively high
(8.6%). We suggest it is partly because our study
population was a homogeneous group, which
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Figure 3. Focal fibrosis in a 48-year-old woman. A mammogram (not shown) revealed a heterogeneously dense breast without remarkable findings.
The patient had a history of contralateral breast carcinoma 2 years previously. Transverse (A) and longitudinal (B) sonograms reveal a round, isoechoic
nodule with a microlobulated margin. We suggested it was a category 4A lesion, and focal fibrosis was diagnosed by a sonographically guided core
biopsy. The lesion was diminished in size on follow-up sonographic examination after 26 months. 
A B
Figure 4. Focal fibrosis in a 41-year-old woman. A left mediolateral oblique mammogram (A) reveals architectural distortion in the upper outer breast
(arrow). A transverse sonogram (B) of the same area reveals an irregularly shaped and spiculated mass with an echogenic halo (arrows), highly sugges-
tive of a malignancy (category 4C). The core biopsy revealed focal fibrosis. Excision was recommended because of imaging-pathologic discordance.
Excisional biopsy revealed fibrosis. 
A B
was confirmed by sonographically guided biopsy
of nonpalpable lesions, in contrast to another
study, which included a sonographically guided
core biopsy as well as a stereotactic biopsy or sur-
gical excision.2–7 In addition to this, focal fibrosis
is frequently shown as a mass on sonographic
examinations, so this is more frequently diag-
nosed by a sonographically guided core biopsy
than by a stereotactic biopsy, which frequently
targets microcalcifications rather than masses.
Imaging findings of focal fibrosis that have
been reported are nonspecific and variable.2–7
Most of them may be present with well-circum-
scribed benign-appearing masses and are suit-
able for a follow-up protocol, but some cases of
focal fibrosis have a suggestive finding of an
irregularly shaped, not circumscribed or paral-
lel-oriented, hypoechoic mass with posterior
shadowing.2–7 However, in our study, 51.8% of
the cases of focal fibrosis were categorized as 4
(suggestive of malignancy) and needed biopsy,
but most of them were category 4A lesions, so we
could regard the benign biopsy results as a con-
cordant finding. Sklair-Levy et al5 evaluated the
imaging findings of 64 cases of focal fibrosis,
including 26 palpable lesions. They found that
only 25% of focal fibrosis had a combination of
sonographically suggestive findings. They evalu-
ated the sonographic findings according to the
criteria of Stavros et al,16 but they did not regard
the irregular margin as a suggestive finding. An
irregular margin, including the suggestive classi-
fication, would have raised the rate to at least
40.6% (26/64). In addition, they reported that
90.6% (58/64) of focal fibrosis were hypoechoic,
but in our study, 75% (42/56) were isoechoic,
and only 21.4% (12/56) were hypoechoic. We
suggest that it is noteworthy that our study only
included nonpalpable lesions (mean size of
mass, 9.4 mm; theirs, 19 mm). Posterior features
were also different. In our study, 14.3% (8/56)
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Table 3. Mammographic Findings of Focal Fibrosis
(n = 51)
Mammographic Findings Cases (%)
Negative 33 (64.7)
Mass without calcifications 12 (23.5) 
Mass with calcifications 2 (3.9)
Asymmetry 2 (3.9)
Architectural distortion 2 (3.9) 
Total 51 (100)
Table 4. Final Assessment According to BI-RADS 
(n = 56)
Final Assessment Category Cases (%)
Category 3 27 (48.2)
Category 4 29 (51.8)
4A 26 (46.4)
4B 2 (3.6)
4C 1 (1.8)
Figure 5. Focal fibrosis in a 35-year-old woman. The patient had a lump in her right breast, which turned out to be fibroadenoma. A nonpalpable lesion
was found during the examination of her palpable breast mass. Transverse (A) and longitudinal (B) sonograms reveal an irregularly shaped, hypoechoic
nodule with an angular margin (category 4B). The lesion has a nonparallel orientation. The diagnosis from the core biopsy was focal fibrosis, and the
surgical excision revealed focal fibrosis.
A B
and 5.4% (3/56) showed posterior shadowing
and enhancement, respectively, but they had
rates of 39.1% (25/64) and 17.2% (11/64). We
also suggest that the size of the lesions in our
study was relatively small for showing sufficient
posterior features.
Rosen et al3 and Harvey et al6 reported no false-
negative biopsy results in their study of focal
fibrosis, and Sklair-Levy et al5 reported a 2.7%
(2/74) false-negative biopsy rate, including 1
case of diagnosis delayed for 6 months. There
were no known false-negative biopsy results in
our study. We followed the 49 cases by sono-
graphic examination and mammography for at
least 12 months (mean, 20 months), and there
were no cases of lesion enlargement on the
follow-up images. However, strict radiologic-
pathologic concordance is critical to avoid
false-negative biopsy results. Generally, a 6-
month follow-up protocol for patients having a
concordant diagnosis of a nonspecific benign
result on core biopsy is recommended.17–21
Our study was limited in that only 7 of the 56
lesions had surgical excision, and 4 of the 7
excised lesions did not confirm the core biopsy
diagnosis of focal fibrosis. They were fibrocystic
changes, ductal hyperplasia, and a radial scar at
excision. All of them may have had pathologic
partial fibrosis internally. However, because the
altered surgical pathologic results did not
change the management plan, we do not think
the diagnosis of focal fibrosis by the sonograph-
ically guided core biopsy was inadequate.
In conclusion, focal fibrosis of the breast is a
relatively common pathologic diagnosis in
sonographically guided core biopsy and fre-
quently has the characteristics of a low sugges-
tion of malignancy. Therefore, in cases of focal
fibrosis diagnosed by sonographically guided
core biopsy of nonpalpable lesions, which
show an oval to round nodule with a microlob-
ulated margin, we suggest a 6-month follow-up
management protocol.
References
1. Rosai J. Rosai and Ackerman’s Surgical Pathology.
9th ed. Edinburgh, Scotland: CV Mosby Co; 2004.
2. Revelon G, Sherman ME, Gatewood OM, Brem RF.
Focal fibrosis of the breast: imaging characteristics
and histopathologic correlation. Radiology 2000;
216:255–259.
3. Rosen EL, Soo MS, Bentley RC. Focal fibrosis: a com-
mon breast lesion diagnosed at imaging-guided
core biopsy. AJR Am J Roentgenol 1999; 173:
1657–1662.
4. Venta LA, Wiley EL, Gabriel H, Adler YT. Imaging
features of focal breast fibrosis: mammographic-
pathologic correlation of noncalcified breast lesions.
AJR Am J Roentgenol 1999; 173:309–316.
5. Sklair-Levy M, Samuels TH, Catzavelos C, Hamilton
P, Shumak R. Stromal fibrosis of the breast. AJR Am
J Roentgenol 2001; 177:573–577.
6. Harvey SC, Denison CM, Lester SC, DiPiro PJ, Smith
DN, Meyer JE. Fibrous nodules found at large-core
needle biopsy of the breast: imaging features.
Radiology 1999; 211:535–540.
7. Hermann G, Schwartz IS. Focal fibrous disease of
the breast: mammographic detection of an unap-
preciated condition. AJR Am J Roentgenol 1983;
140:1245–1246.
8. American College of Radiology BI-RADS
Committee. ACR BI-RADS Breast Imaging and
Reporting Data System: Breast Imaging Atlas. 4th
ed. Reston, VA: American College of Radiology,
2003.
9. Gordon PB, Goldenberg SL. Malignant breast mass-
es detected only by ultrasound: a retrospective
review. Cancer 1995; 76:626–630.
10. Kolb TM, Lichy J, Newhouse JH. Occult cancer in
women with dense breasts: detection with screen-
ing US—diagnostic yield and tumor characteristics.
Radiology 1998; 207:191–199.
11. Buchberger W, Niehoff A, Obrist P, DeKoekkoek-
Doll P, Dunser M. Clinically and mammographically
occult breast lesions: detection and classification
with high-resolution sonography. Semin Ultrasound
CT MR 2000; 21:325–336.
12. Kaplan SS. Clinical utility of bilateral whole-breast
US in the evaluation of women with dense breast
tissue. Radiology 2001; 221:641–649.
J Ultrasound Med 2005; 24:1377–1384 1383
You et al
Table 5. Results of Surgical Biopsy
Surgical Biopsy Result Cases (n = 7)
Focal fibrosis 3
Fibrocystic change 2
Ductal hyperplasia 1
Radial scar 1
13. Kolb TM, Lichy J, Newhouse JH. Comparison of the
performance of screening mammography, physical
examination, and breast US and evaluation of fac-
tors that influence them: an analysis of 27,825
patient evaluations. Radiology 2002; 225:165–175. 
14. Crystal P, Strano SD, Shcharynski S, Koretz MJ. Using
sonography to screen women with mammographi-
cally dense breasts. AJR Am J Roentgenol 2003;
181:177–182.
15. Berg WA. Rationale for a trial of screening breast
ultrasound: American College of Radiology Imaging
Network (ACRIN) 6666. AJR Am J Roentgenol 2003;
1225–1228.
16. Stavros AT, Thickman D, Rapp CL, Dennis MA, Parker
SH, Sisney GA. Solid breast nodules: use of sonogra-
phy to distinguish between benign and malignant
lesions. Radiology 1995; 196:123–134.
17. Philpotts LE, Shaheen NA, Carter D, Lange RC, Lee
CH. Comparison of rebiopsy rates after stereotactic
core needle biopsy of the breast with 11-gauge vac-
uum suction probe versus 14-gauge needle and
automatic gun. AJR Am J Roentgenol 1999; 172:
683–687.
18. Shah VI, Raju U, Chitale D, Deshpande V, Gregory N,
Strand V. False-negative core needle biopsies of the
breast: an analysis of clinical, radiologic, and patho-
logic findings in 27 concecutive cases of missed
breast cancer. Cancer 2003; 97:1824–1831.
19. Lee CH, Philpotts LE, Horvath LJ, Tocino I. Follow-up
of breast lesions diagnosed as benign with stereo-
tactic core-needle biopsy: frequency of mammo-
graphic change and false-negative rate. Radiology
1999; 212:189–194.
20. Jackman RJ, Nowels KW, Rodriguez-Soto J, Marzoni
FA Jr, Finkelstein SI, Shepard MJ. Stereotactic, auto-
mated, large-core needle biopsy of nonpalpable
breast lesions: false-negative and histologic underes-
timation rates after long-term follow-up. Radiology
1999; 210:799–805.
21. Liberman L, Drotman M, Morris EA, et al. Imaging-
histologic discordance at percutaneous breast biop-
sy. Cancer 2000; 89:2538–2546.
1384 J Ultrasound Med 2005; 24:1377–1384
Focal Fibrosis of the Breast
